Red herring prospectus

MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual Listing

Retrieved on: 
Monday, July 12, 2021
Financial markets, Finance, Stock market, Financial economics, SEC filings, Security, 73rd United States Congress, U.S. Securities and Exchange Commission, Equity securities, Red herring prospectus, Securities Act

All shares to be sold in the Offering will be offered by MaxCyte.

Key Points: 
  • All shares to be sold in the Offering will be offered by MaxCyte.
  • The number of shares to be offered and the price range for the proposed Offering have not yet been determined.
  • The Offering is expected to commence after the SEC completes its review process, subject to market and other conditions.
  • A registration statement relating to these securities has been filed with the SEC, but has not yet become effective.

Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters’ Full Exercise of Option to Purchase Additional Shares

Retrieved on: 
Thursday, July 8, 2021
Stock market, Actuarial science, Underwriting, Option, Initial public offering, Finance, Corporate finance, Money, Greenshoe, Academic disciplines, Red herring prospectus

In addition, Nyxoah announced today that the underwriters of the Offering have exercised their option to purchase additional shares in full.

Key Points: 
  • In addition, Nyxoah announced today that the underwriters of the Offering have exercised their option to purchase additional shares in full.
  • The option to purchase additional shares granted to the underwriters was for the purchase of up to an additional 425,250 new ordinary shares, at the public offering price of US$30 per share, before underwriting discounts and commissions.
  • This exercise will bring the total gross proceeds of the Offering to US$97.8 million before deducting underwriting discounts and commissions and estimated offering expenses.
  • The closing of the exercise of the option to purchase additional shares is expected to occur on July 9, 2021, subject to the satisfaction of customary closing conditions.

Agrico Acquisition Corp. Announces Pricing of $125 Million Initial Public Offering

Retrieved on: 
Wednesday, July 7, 2021
Financial markets, Stock market, U.S. Securities and Exchange Commission, Initial public offering, Security, Forward-looking statement, Underwriting, Registration statement, United States securities law, Red herring prospectus

The Company has granted the underwriters a 45-day option to purchase up to 1,875,000 additional units at the initial public offering price to cover over-allotments, if any.

Key Points: 
  • The Company has granted the underwriters a 45-day option to purchase up to 1,875,000 additional units at the initial public offering price to cover over-allotments, if any.
  • A registration statement relating to the securities sold in the initial public offering was declared effective by the U.S. Securities and Exchange Commission (the SEC) on July 7, 2021.
  • This press release contains statements that constitute forward-looking statements, including with respect to the Companys initial public offering (IPO) and search for an initial business combination.
  • Agrico Acquisition Corp. undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Biofrontera Inc. seeks IPO in the USA

Retrieved on: 
Tuesday, July 6, 2021
Financial economics, Finance, Financial markets, Stock market, Initial public offering, Corporate finance, Security, Public offering, Red herring prospectus, Primary market

Leverkusen, Germany, July 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG currently holds 100 % of the shares of the US-based Biofrontera Inc.

Key Points: 
  • Leverkusen, Germany, July 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG currently holds 100 % of the shares of the US-based Biofrontera Inc.
    Biofrontera AG had already announced that opportunities for capital raises were being evaluated including a potential initial public offering ("IPO") of Biofrontera Inc. in the United States.
  • The main objectives of an IPO of Biofrontera Inc. would be to raise additional capital to fund its growth of operations, to create a public market for its shares and to facilitate future access to the capital market.
  • A registration statement relating to the securities to be offered in the IPO has been filed with the Securities and Exchange Commission but has not yet become effective.
  • These securities may not be sold nor may offers to buy these securities be accepted prior to the time the registration statement becomes effective.

Traeger Announces Filing of Registration Statement for Proposed Initial Public Offering

Retrieved on: 
Tuesday, July 6, 2021
Home Goods, Retail, Food, Beverage, Finance, Financial markets, Money, SEC filings, Stock market, Initial public offering, U.S. Securities and Exchange Commission, Security, Form S-1, Morgan Stanley, Red herring prospectus

TGPX Holdings I LLC (Traeger) today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.

Key Points: 
  • TGPX Holdings I LLC (Traeger) today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.
  • The number of shares to be offered and the price range for the proposed offering have not yet been determined.
  • Morgan Stanley, Jefferies, Baird, and William Blair will act as joint lead book-running managers for the proposed offering.
  • A registration statement on Form S-1 relating to the proposed offering has been filed with the SEC but has not yet become effective.

Integrated Media Technology Limited Announces Registered Direct Offering of Ordinary Shares

Retrieved on: 
Tuesday, July 6, 2021
Initial public offering, Financial markets, Prospectus, U.S. Securities and Exchange Commission, Finance, Corporate finance, Registration statement, Stock market, SEC filings, Shelf registration, Red herring prospectus

The Offering is being made pursuant to the Company's "shelf" Registration Statement on Form F-3 (File No.

Key Points: 
  • The Offering is being made pursuant to the Company's "shelf" Registration Statement on Form F-3 (File No.
  • The Ordinary Shares are being offered only in the United States by the means of a prospectus supplement.
  • The prospectus supplement and the accompanying prospectus relating to the registered direct offering is expected to be filed with the SEC on July 7, 2021.
  • Electronic copies of the prospectus supplement and the accompanying prospectus relating to the registered direct offering may be obtained, when available, at the SEC's website at http://www.sec.gov .

EQS-News: Terraoil Announces Offering of up to 24'000'000 Shares Following Approval of Prospectus by the Prospectus Office of SIX Exchange Regulation AG

Retrieved on: 
Monday, July 5, 2021
Initial public offering, Prospectus, Forward-looking statement, Red herring prospectus

The prospectus for the Offering has been filed with and approved by the Prospectus Office of SIX Exchange Regulation AG on June 30, 2021.

Key Points: 
  • The prospectus for the Offering has been filed with and approved by the Prospectus Office of SIX Exchange Regulation AG on June 30, 2021.
  • The prospectus is valid for a period of twelve months commencing on July 1, 2021.
  • Investors should base their decision to purchase shares of Terraoil Swiss AG exclusively on the official prospectus, which can be downloaded from the company's website (https://terraoil.swiss/publications).
  • The forward-looking statements contained in this media release are based on the views and assumptions of Terraoil Swiss AG as of this date and Terraoil Swiss AG does not assume any obligation to update or revise this media release.

Clarios Files Registration Statement with SEC for an Initial Public Offering

Retrieved on: 
Friday, July 2, 2021
Environment, Technology, Other Energy, Utilities, Other Technology, Energy, Hardware, Retail, Supply chain management, Financial markets, Stock market, Finance, Money, Security, Stock, Ticker symbol, Red herring prospectus

Clarios has applied to list its Common Stock and Mandatory Convertible Preferred Stock on the New York Stock Exchange under the ticker symbols BTRY and BTRY PRA, respectively.

Key Points: 
  • Clarios has applied to list its Common Stock and Mandatory Convertible Preferred Stock on the New York Stock Exchange under the ticker symbols BTRY and BTRY PRA, respectively.
  • BofA Securities and J.P. Morgan are acting as joint lead book-running managers for the offerings and as representatives of the underwriters for the offerings.
  • A registration statement relating to these securities has been filed with the SEC but has not yet become effective.
  • These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.

BioSig Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Friday, July 2, 2021
Initial public offering, Finance, Financial economics, Financial markets, Prospectus, Public offering, U.S. Securities and Exchange Commission, Red herring prospectus, Regulation S-K

The gross proceeds to BioSig from this offering are expected to be approximately $10 million, or approximately $11.5 million if the underwriter exercises its 30-day option to purchase an additional 15% of the number of shares of common stock offered in the public offering in full, before deducting the underwriting discounts and commissions and estimated offering expenses payable by BioSig.The offering is expected to close on July 7, 2021, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The gross proceeds to BioSig from this offering are expected to be approximately $10 million, or approximately $11.5 million if the underwriter exercises its 30-day option to purchase an additional 15% of the number of shares of common stock offered in the public offering in full, before deducting the underwriting discounts and commissions and estimated offering expenses payable by BioSig.The offering is expected to close on July 7, 2021, subject to the satisfaction of customary closing conditions.
  • Laidlaw & Company (UK) Ltd. is acting as sole book-running manager for the offering.
  • 333-251859) relating to the public offering of the shares of common stock described above was previously filed with the Securities and Exchange Commission (SEC) and declared effective on January 12, 2021.
  • A preliminary prospectus supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available on the SEC's website at www.sec.gov.

Zivo Bioscience, Inc. Announces Closing of Underwriters’ Partial Exercise of Over-Allotment Option in Connection with its Previously Announced Public Offering

Retrieved on: 
Friday, July 2, 2021
SEC filings, U.S. Securities and Exchange Commission, Financial markets, Stock market, Registration statement, Agencies of the United States government, Security, Underwriting, Form S-1, Red herring prospectus, Regulation S-K

ZIVOreceived gross proceeds ofapproximately $748,500, before deducting underwriting discounts and commissions and other estimated offering expenses.

Key Points: 
  • ZIVOreceived gross proceeds ofapproximately $748,500, before deducting underwriting discounts and commissions and other estimated offering expenses.
  • Maxim Group LLC acted as lead book running manager, and Joseph Gunnar & Co., LLC acted as co-book running manager for the offering.
  • The offering was conducted pursuant to the Company's registration statement on Form S-1 (File No.
  • 333-251221), as amended, previously filed with and subsequently declared effective by the Securities and Exchange Commission (SEC), and the Companys registration statement on Form S-1MEF (File No.